-+ 0.00%
-+ 0.00%
-+ 0.00%

Immix Biopharma To Present An NXC-201 Abstract At American Society Of Hematology Annual Meeting, December 12-15

Benzinga·11/04/2026 14:20:07
Diffusion vocale

ASH Oral Presentation Details:

Event    68th ASH Annual Meeting and Exposition, New Orleans, LA
Title    "45-patient safety and efficacy data for NXC-201 from Nexicart-2, the first U.S. trial of CAR-T in relapsed/refractory AL amyloidosis"
Presentation

Date/Time (Central Time)    
Publication #826
Session Date: Monday, December 14, 2026
Session Name: 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Advancing Treatment Strategies in AL Amyloidosis
Session Time: 10:30 AM -12:00 PM
Presentation Time: 11:15 AM